CEO: Merck on pace to distribute tens of millions of doses of COVID-19 antiviral pills if approved

The CEO of Merck said during an interview on CNBC that the biopharmaceutical company was on pace to distribute tens of millions of the COVID-19 antiviral pill it developed with Ridgeback Biotherapeutics once it receives federal approval.“Right now…